Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
1.
Proc (Bayl Univ Med Cent) ; 36(1): 140-141, 2023.
Article in English | MEDLINE | ID: covidwho-2246818
2.
Journal of the Royal Statistical Society: Series A (Statistics in Society) ; 185(S1), 2022.
Article in English | Web of Science | ID: covidwho-2193233

ABSTRACT

We propose a new framework to model the COVID-19 epidemic of the United Kingdom at the local authority level. The model fits within a general framework for semi-mechanistic Bayesian models of the epidemic based on renewal equations, with some important innovations, including a random walk modelling the reproduction number, incorporating information from different sources, including surveys to estimate the time-varying proportion of infections that lead to reported cases or deaths, and modelling the underlying infections as latent random variables. The model is designed to be updated daily using publicly available data. We envisage the model to be useful for now-casting and short-term projections of the epidemic as well as estimating historical trends. The model fits are available on a public website: . The model is currently being used by the Scottish government to inform their interventions.

3.
JAAD Int ; 9: 155, 2022 Dec.
Article in English | MEDLINE | ID: covidwho-2041917
4.
Sci Rep ; 11(1): 16342, 2021 08 11.
Article in English | MEDLINE | ID: covidwho-1354114

ABSTRACT

The UK and Sweden have among the worst per-capita COVID-19 mortality in Europe. Sweden stands out for its greater reliance on voluntary, rather than mandatory, control measures. We explore how the timing and effectiveness of control measures in the UK, Sweden and Denmark shaped COVID-19 mortality in each country, using a counterfactual assessment: what would the impact have been, had each country adopted the others' policies? Using a Bayesian semi-mechanistic model without prior assumptions on the mechanism or effectiveness of interventions, we estimate the time-varying reproduction number for the UK, Sweden and Denmark from daily mortality data. We use two approaches to evaluate counterfactuals which transpose the transmission profile from one country onto another, in each country's first wave from 13th March (when stringent interventions began) until 1st July 2020. UK mortality would have approximately doubled had Swedish policy been adopted, while Swedish mortality would have more than halved had Sweden adopted UK or Danish strategies. Danish policies were most effective, although differences between the UK and Denmark were significant for one counterfactual approach only. Our analysis shows that small changes in the timing or effectiveness of interventions have disproportionately large effects on total mortality within a rapidly growing epidemic.


Subject(s)
COVID-19/epidemiology , COVID-19/prevention & control , Health Policy , Models, Theoretical , COVID-19/therapy , Denmark/epidemiology , Humans , Sweden/epidemiology , United Kingdom/epidemiology
5.
Science ; 371(6536)2021 03 26.
Article in English | MEDLINE | ID: covidwho-1061088

ABSTRACT

After initial declines, in mid-2020 a resurgence in transmission of novel coronavirus disease (COVID-19) occurred in the United States and Europe. As efforts to control COVID-19 disease are reintensified, understanding the age demographics driving transmission and how these affect the loosening of interventions is crucial. We analyze aggregated, age-specific mobility trends from more than 10 million individuals in the United States and link these mechanistically to age-specific COVID-19 mortality data. We estimate that as of October 2020, individuals aged 20 to 49 are the only age groups sustaining resurgent SARS-CoV-2 transmission with reproduction numbers well above one and that at least 65 of 100 COVID-19 infections originate from individuals aged 20 to 49 in the United States. Targeting interventions-including transmission-blocking vaccines-to adults aged 20 to 49 is an important consideration in halting resurgent epidemics and preventing COVID-19-attributable deaths.


Subject(s)
COVID-19/epidemiology , COVID-19/transmission , Epidemics , Adolescent , Adult , Age Factors , Basic Reproduction Number , COVID-19/mortality , COVID-19/prevention & control , COVID-19 Vaccines , Cell Phone , Child , Child, Preschool , Communicable Disease Control , Epidemics/prevention & control , Humans , Infant , Middle Aged , Models, Theoretical , Pandemics/prevention & control , Schools , United States/epidemiology , Young Adult
6.
Nat Commun ; 11(1): 6189, 2020 12 03.
Article in English | MEDLINE | ID: covidwho-960314

ABSTRACT

As of 1st June 2020, the US Centres for Disease Control and Prevention reported 104,232 confirmed or probable COVID-19-related deaths in the US. This was more than twice the number of deaths reported in the next most severely impacted country. We jointly model the US epidemic at the state-level, using publicly available death data within a Bayesian hierarchical semi-mechanistic framework. For each state, we estimate the number of individuals that have been infected, the number of individuals that are currently infectious and the time-varying reproduction number (the average number of secondary infections caused by an infected person). We use changes in mobility to capture the impact that non-pharmaceutical interventions and other behaviour changes have on the rate of transmission of SARS-CoV-2. We estimate that Rt was only below one in 23 states on 1st June. We also estimate that 3.7% [3.4%-4.0%] of the total population of the US had been infected, with wide variation between states, and approximately 0.01% of the population was infectious. We demonstrate good 3 week model forecasts of deaths with low error and good coverage of our credible intervals.


Subject(s)
COVID-19/epidemiology , Pandemics/statistics & numerical data , Bayes Theorem , COVID-19/transmission , Humans , Models, Statistical , United States/epidemiology , Virus Diseases/epidemiology
7.
J R Soc Interface ; 17(172): 20200596, 2020 11.
Article in English | MEDLINE | ID: covidwho-944564

ABSTRACT

Knowing COVID-19 epidemiological distributions, such as the time from patient admission to death, is directly relevant to effective primary and secondary care planning, and moreover, the mathematical modelling of the pandemic generally. We determine epidemiological distributions for patients hospitalized with COVID-19 using a large dataset (N = 21 000 - 157 000) from the Brazilian Sistema de Informação de Vigilância Epidemiológica da Gripe database. A joint Bayesian subnational model with partial pooling is used to simultaneously describe the 26 states and one federal district of Brazil, and shows significant variation in the mean of the symptom-onset-to-death time, with ranges between 11.2 and 17.8 days across the different states, and a mean of 15.2 days for Brazil. We find strong evidence in favour of specific probability density function choices: for example, the gamma distribution gives the best fit for onset-to-death and the generalized lognormal for onset-to-hospital-admission. Our results show that epidemiological distributions have considerable geographical variation, and provide the first estimates of these distributions in a low and middle-income setting. At the subnational level, variation in COVID-19 outcome timings are found to be correlated with poverty, deprivation and segregation levels, and weaker correlation is observed for mean age, wealth and urbanicity.


Subject(s)
COVID-19/epidemiology , Pandemics , SARS-CoV-2 , Adolescent , Adult , Aged , Aged, 80 and over , Bayes Theorem , Brazil/epidemiology , COVID-19/mortality , Child , Child, Preschool , Female , Hospitalization/statistics & numerical data , Hospitals/statistics & numerical data , Humans , Infant , Infant, Newborn , Male , Middle Aged , Models, Statistical , Pandemics/statistics & numerical data , Poverty , Probability , Time Factors , Young Adult
8.
Nature ; 584(7820): 257-261, 2020 08.
Article in English | MEDLINE | ID: covidwho-582068

ABSTRACT

Following the detection of the new coronavirus1 severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and its spread outside of China, Europe has experienced large epidemics of coronavirus disease 2019 (COVID-19). In response, many European countries have implemented non-pharmaceutical interventions, such as the closure of schools and national lockdowns. Here we study the effect of major interventions across 11 European countries for the period from the start of the COVID-19 epidemics in February 2020 until 4 May 2020, when lockdowns started to be lifted. Our model calculates backwards from observed deaths to estimate transmission that occurred several weeks previously, allowing for the time lag between infection and death. We use partial pooling of information between countries, with both individual and shared effects on the time-varying reproduction number (Rt). Pooling allows for more information to be used, helps to overcome idiosyncrasies in the data and enables more-timely estimates. Our model relies on fixed estimates of some epidemiological parameters (such as the infection fatality rate), does not include importation or subnational variation and assumes that changes in Rt are an immediate response to interventions rather than gradual changes in behaviour. Amidst the ongoing pandemic, we rely on death data that are incomplete, show systematic biases in reporting and are subject to future consolidation. We estimate that-for all of the countries we consider here-current interventions have been sufficient to drive Rt below 1 (probability Rt < 1.0 is greater than 99%) and achieve control of the epidemic. We estimate that across all 11 countries combined, between 12 and 15 million individuals were infected with SARS-CoV-2 up to 4 May 2020, representing between 3.2% and 4.0% of the population. Our results show that major non-pharmaceutical interventions-and lockdowns in particular-have had a large effect on reducing transmission. Continued intervention should be considered to keep transmission of SARS-CoV-2 under control.


Subject(s)
Coronavirus Infections/epidemiology , Coronavirus Infections/prevention & control , Pandemics/prevention & control , Pneumonia, Viral/epidemiology , Pneumonia, Viral/prevention & control , Basic Reproduction Number , COVID-19 , Coronavirus Infections/mortality , Coronavirus Infections/transmission , Europe/epidemiology , Humans , Pneumonia, Viral/mortality , Pneumonia, Viral/transmission
SELECTION OF CITATIONS
SEARCH DETAIL